Potential hazard of nebulised salbutamol in patients with haemoptysis.
作者信息
Ullah M I, Fegan O
出版信息
Br Med J (Clin Res Ed). 1983 Mar 12;286(6368):844-5. doi: 10.1136/bmj.286.6368.844-a.
Abstract
摘要
相似文献
1
Potential hazard of nebulised salbutamol in patients with haemoptysis.咯血患者雾化吸入沙丁胺醇的潜在危害。
Br Med J (Clin Res Ed). 1983 Mar 12;286(6368):844-5. doi: 10.1136/bmj.286.6368.844-a.
2
Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.雾化吸入沙丁胺醇后发现的隐匿性冠状动脉疾病
Br Heart J. 1994 Aug;72(2):181. doi: 10.1136/hrt.72.2.181.
3
Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants.喘息性婴儿雾化吸入沙丁胺醇后肺功能出现矛盾性恶化。
Lancet. 1986;2(8521-22):1424-5. doi: 10.1016/s0140-6736(86)92735-2.
4
Nebulised salbutamol and angina.雾化沙丁胺醇与心绞痛
Br Med J (Clin Res Ed). 1982 Sep 18;285(6344):796-7. doi: 10.1136/bmj.285.6344.796.
5
Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.与雾化异丙托溴铵和沙丁胺醇相关的急性闭角型青光眼。
BMJ. 1992 Feb 1;304(6822):320. doi: 10.1136/bmj.304.6822.320-a.
6
Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma.静脉注射与雾化吸入沙丁胺醇在重度哮喘初始治疗中的比较
Br Med J. 1978 Jan 14;1(6105):84. doi: 10.1136/bmj.1.6105.84.
7
Nebulised salbutamol in life-threatening asthma.
Br Med J. 1979 Jun 16;1(6178):1628. doi: 10.1136/bmj.1.6178.1628.
8
Randomised trial of intravenous salbutamol in early management of acute severe asthma in children.静脉注射沙丁胺醇用于儿童急性重度哮喘早期治疗的随机试验
Lancet. 1997 Feb 1;349(9048):301-5. doi: 10.1016/S0140-6736(96)06358-1.
9
Experiences with large doses of beta 2-agonists inhaled from nebulizers.使用雾化器吸入大剂量β2受体激动剂的经验。
Postgrad Med J. 1983;59 Suppl 3:71-2.
10
Salbutamol and hypokalaemia.沙丁胺醇与低钾血症
Lancet. 1976 Jun 12;1(7972):1302. doi: 10.1016/s0140-6736(76)91780-3.
引用本文的文献
1
Physiotherapy in cystic fibrosis.囊性纤维化的物理治疗
J R Soc Med. 2000;93 Suppl 38(Suppl 38):27-36.
2
Adverse reactions to beta 2-agonist bronchodilators.β2 受体激动剂支气管扩张剂的不良反应。
Med Toxicol. 1986 Jul-Aug;1(4):286-99. doi: 10.1007/BF03259844.
Zotero 插件